Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,751 public trials 635 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Albuterol HFA MDI in Pediatric Participants With Asthma

NCT00577655

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Pediatric Care Medical Group, Inc. Huntington Beach, California, United States
  • California Allergy & Asthma Medical Group Palmdale, California, United States
  • Center for Clinical Trials, LLC Paramount, California, United States
  • Integrated Research Group, Inc Riverside, California, United States
View all 13 locations
View Trial Details
Completed

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

NCT02139644

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12397 Birmingham, Alabama, United States
  • Teva Investigational Site 12375 Glendale, Arizona, United States
  • Teva Investigational Site 12395 Cypress, California, United States
  • Teva Investigational Site 12476 Encinitas, California, United States
View all 140 locations
View Trial Details
Completed

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

NCT02452190

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13212 Birmingham, Alabama, United States
  • Teva Investigational Site 13241 Flagstaff, Arizona, United States
  • Teva Investigational Site 13194 Glendale, Arkansas, United States
  • Teva Investigational Site 13215 Bakersfield, California, United States
View all 226 locations
View Trial Details
Completed

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

NCT02040779

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Teva Investigational Site 12813 Huntington Beach, California, United States
  • Teva Investigational Site 10944 Mission Viejo, California, United States
  • Teva Investigational Site 10946 Orange, California, United States
  • Teva Investigational Site 10963 Rolling Hills Estates, California, United States
View all 47 locations
View Trial Details
Completed

Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study

NCT02198664

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UC San Diego San Diego, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details
Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

NCT02031640

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 10851 Costa Mesa, California, United States
  • Teva Investigational Site 10849 Huntington Beach, California, United States
  • Teva Investigational Site 10872 Huntington Beach, California, United States
  • Teva Investigational Site 10833 Long Beach, California, United States
View all 131 locations
View Trial Details
Completed

A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

NCT01058863

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Clinical Study Site Huntington Beach, California, United States
  • Teva Clinical Study Site Rolling Hills Est., California, United States
  • Teva Clinical Study Site San Diego, California, United States
  • Teva Clinical Study Site Colorado Springs, Colorado, United States
View all 13 locations
View Trial Details
Completed

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

NCT02501629

Conditions
Asthma, Bronchial Diseases, Elevated Blood Eosinophils, +8 more
Locations
  • Teva Investigational Site 13357 Bakersfield, California, United States
  • Teva Investigational Site 13365 Long Beach, California, United States
  • Teva Investigational Site 13371 Clermont, Florida, United States
  • Teva Investigational Site 13351 Homestead, Florida, United States
View all 127 locations
View Trial Details
Completed

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

NCT02437604

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13178 Raleigh, North Carolina, United States
  • Teva Investigational Site 13177 Edmond, Oklahoma, United States
  • Teva Investigational Site 13179 San Antonio, Texas, United States
View Trial Details

Related conditions